Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo.
Tao Y, Lamas V, Du W, Zhu W, Li Y, Whittaker MN, Zuris JA, Thompson DB, Rameshbabu AP, Shu Y, Gao X, Hu JH, Pei C, Kong WJ, Liu X, Wu H, Kleinstiver BP, Liu DR, Chen ZY.
Tao Y, et al. Among authors: rameshbabu ap.
Nat Commun. 2023 Aug 15;14(1):4928. doi: 10.1038/s41467-023-40476-7.
Nat Commun. 2023.
PMID: 37582836
Free PMC article.